EMEA-000132-PIP01-07-M04 - paediatric investigation plan

Voclosporin

Key facts

• Active Substance:
  Voclosporin
• Therapeutic area:
  Ophthalmology
• Decision number:
  P/0085/2013
• PIP number:
  EMEA-000132-PIP01-07-M04
• Pharmaceutical form(s):
  • Oral liquid
  • Capsule (soft)
• Condition(s) / indication(s):
  Treatment of non-infectious uveitis
• Route(s) of administration:
  Oral use
• Contact for public enquiries:

  Lux Biosciences GmbH

  E-mail: [e-mail]; Country: Germany; Tel. [phone]

• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  29/04/2013

Decision

P/0085/2013: EMA decision of 29 April 2013 on the acceptance of a modification of an agreed paediatric investigation plan for voclosporin (EMEA-000132-PIP01-07-M04)

AdoptedReference Number: EMA/201721/2013